The lifestyle guru appeared on The Tonight Show on Monday night (January 27), where host Jimmy Fallon asked her if she would ...

Martha Stewart is still dreaming of appearing on Saturday Night Live. On a new episode of The Tonight Show Starring Jimmy ...

and of making false statements to federal investigators relating to her selling her stake in the biopharmaceutical company ImClone Systems in December 2001. In addition to her five-month sentence ...

The scandal has been disturbing to the biotechnology and pharmaceutical industries, in part because it echoes the debacle that rocked ImClone Systems not long ago. Sam Waksal, ImClone's former CEO, is ...

However, it all crumbled when Stewart was accused of insider trading after selling her shares in ImClone Systems in 2001. Related: How Al Pacino went from a net worth of $50 million to broke ...

After selling her stake in ImClone Systems, a biopharmaceutical company, in December 2001, investigators questioned her about the trade in early 2002. Both Stewart and her stockbroker, Peter ...

Other companies that joined the ranks of top revenue gainers in 2006 included Amylin, which launched its first two products in 2005, and oncology firms Celgene and ImClone Systems (New York).

This way, even if they receive insider information, such insider trading would be legal. For a good reason, Martha Stewart’s ImClone Systems’ stock sale is likely the most widely known insider trading ...

Kim’s career also includes leadership roles at ImClone Systems, OSI Pharmaceuticals, Domain Associates and Safeguard Scientifics. He holds a master’s degree from The Wharton School and a bachelor of ...